Literature DB >> 19921130

Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.

Gerd Bodlaj1, Rainer Hubmann, Karim Saleh, Georg Biesenbach, Erich Pohanka, Tatjana Stojakovic, Jörg Berg.   

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) plays a key role in the regulation of volume homeostasis, and elevated blood levels of BNP are associated with end-stage renal disease. Renal transplantation leads to a decrease of elevated BNP levels with established graft function. Assessment of N-terminal pro-BNP (NT-proBNP) is established as reflecting volume homeostasis, and we therefore studied the relationship between NT-proBNP and allograft function in a prospective study.
METHODS: NT-proBNP was assessed in 76 patients with end-stage renal disease undergoing renal transplantation. Patients were grouped according to immediate or delayed graft function. The degree of allograft function was assessed from the estimated glomerular filtration rate according to the MDRD formula.
RESULTS: In patients with immediate graft function (n = 48), median NT-proBNP decreased immediately after transplantation; in patients with delayed function (n = 28), median NT-proBNP first increased and then decreased as function improved. Patients with early acute rejection showed significantly higher NT-proBNP levels prior to transplantation than patients without rejection. NT-proBNP levels measured 2 or 3 weeks post-transplant were significantly correlated with the estimated glomerular filtration rate 1 year after transplantation.
CONCLUSIONS: An association was observed between renal allograft function and post-transplant levels of NT-proBNP. The association was not found to be a useful general predictor for graft function in individual patients in a clinical setting, as the range of NT-proBNP levels measured was too wide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921130     DOI: 10.1007/s00508-009-1248-x

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  32 in total

Review 1.  Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease.

Authors:  Gerd Bodlaj; Robert Pichler; Walter Brandstätter; Margit Hatzl-Griesenhofer; Wilhelmine Maschek; Georg Biesenbach; Jörg Berg
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

Review 2.  Molecular biology of natriuretic peptides and nitric oxide synthases.

Authors:  B C Kone
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

3.  Assessment of plasma neopterin in clinical kidney transplantation.

Authors:  A J Schäfer; V Daniel; K Dreikorn; G Opelz
Journal:  Transplantation       Date:  1986-04       Impact factor: 4.939

4.  Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis.

Authors:  K Nitta; A Kawashima; W Yumura; M Naruse; T Oba; T Kabaya; H Nihei
Journal:  Am J Nephrol       Date:  1998       Impact factor: 3.754

5.  BNP and N-terminal proBNP are both extracted in the normal kidney.

Authors:  J P Goetze; G Jensen; S Møller; F Bendtsen; J F Rehfeld; J H Henriksen
Journal:  Eur J Clin Invest       Date:  2006-01       Impact factor: 4.686

6.  Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection.

Authors:  R Weimer; S Zipperle; V Daniel; S Carl; G Staehler; G Opelz
Journal:  Transplantation       Date:  1996-12-15       Impact factor: 4.939

7.  Changes in plasma B-type natriuretic peptide after allograft renal transplantation.

Authors:  Tie-Min Wei; Lie Jin; Ling-Chun Lv; Bao-Jin Zhang; Le-Xin Wang
Journal:  Nephrology (Carlton)       Date:  2007-02       Impact factor: 2.506

8.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 9.  B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

Authors:  Peter A McCullough; Torbjørn Omland; Alan S Maisel
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

10.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

View more
  3 in total

1.  B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.

Authors:  Petr Jarolim; Brian L Claggett; Michael J Conrad; Myra A Carpenter; Anastasia Ivanova; Andrew G Bostom; John W Kusek; Lawrence G Hunsicker; Paul F Jacques; Lisa Gravens-Mueller; Peter Finn; Scott D Solomon; Daniel E Weiner; Andrew S Levey; Marc A Pfeffer
Journal:  Transplantation       Date:  2017-01       Impact factor: 4.939

Review 2.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

3.  Temporal trajectory of B-type natriuretic peptide in patients with CKD stages 3 and 4, dialysis, and kidney transplant.

Authors:  Matthew A Roberts; David L Hare; Ken Sikaris; Francesco L Ierino
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.